A Review of Bioeffects Induced by Focused Ultrasound Combined with Microbubbles on the Neurovascular Unit
Overview
Endocrinology
Neurology
Authors
Affiliations
Focused ultrasound combined with circulating microbubbles (FUS+MB) can transiently enhance blood-brain barrier (BBB) permeability at targeted brain locations. Its great promise in improving drug delivery to the brain is reflected by a rapidly growing number of clinical trials using FUS+MB to treat various brain diseases. As the clinical applications of FUS+MB continue to expand, it is critical to have a better understanding of the molecular and cellular effects induced by FUS+MB to enhance the efficacy of current treatment and enable the discovery of new therapeutic strategies. Existing studies primarily focus on FUS+MB-induced effects on brain endothelial cells, the major cellular component of BBB. However, bioeffects induced by FUS+MB expand beyond the BBB to cells surrounding blood vessels, including astrocytes, microglia, and neurons. Together these cell types comprise the neurovascular unit (NVU). In this review, we examine cell-type-specific bioeffects of FUS+MB on different NVU components, including enhanced permeability in endothelial cells, activation of astrocytes and microglia, as well as increased intraneuron protein metabolism and neuronal activity. Finally, we discuss knowledge gaps that must be addressed to further advance clinical applications of FUS+MB.
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer's Disease.
Sovrea A, Bosca A, Dronca E, Constantin A, Crintea A, Sufletel R Biomedicines. 2025; 13(1).
PMID: 39857667 PMC: 11760896. DOI: 10.3390/biomedicines13010084.
Shen Y, Jethe J, Reid A, Hehir J, Amaral M, Ren C Commun Biol. 2025; 8(1):12.
PMID: 39762513 PMC: 11704147. DOI: 10.1038/s42003-024-07356-2.
Angolano C, Hansen E, Ajjawi H, Nowlin P, Zhang Y, Thunemann N Biomed Pharmacother. 2024; 182:117762.
PMID: 39719739 PMC: 11803570. DOI: 10.1016/j.biopha.2024.117762.
The future of transcranial ultrasound as a precision brain interface.
Murphy K, Fouragnan E PLoS Biol. 2024; 22(10):e3002884.
PMID: 39471185 PMC: 11521279. DOI: 10.1371/journal.pbio.3002884.
Sharma D, Petchiny T, Czarnota G Cancers (Basel). 2024; 16(18).
PMID: 39335153 PMC: 11431001. DOI: 10.3390/cancers16183181.